Logo

Course

Universal Hepatitis C Screening among Pregnant Persons to Reduce Stigma and Advance Elimination

Details

Published Date: 08/01/2025

CE Credit: No CE

Description

This course will provide an overview for the rationale behind universal hepatitis C (HCV) screening among pregnant persons. It will review clinical management for persons who screen positive for HCV as well as clinical recommendations for infants born to HCV-positive others. Finally, the course will discuss stigma and bias associated with HCV and substance use in pregnancy, and provide attendees with New York State resources for the clinical management of pregnant persons with HCV

Presenter(s)

Tatyana Kushner,MD, MSCE

Tatyana Kushner, MD, MSCE is Associate Professor in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai here in New York, with a joint appointment in the department of Obstetrics and Gynecology. Dr. Kushner’s clinical and research interests focus on clinical predictors, epidemiological trends and outcomes in viral hepatitis and in liver disease during pregnancy. Her clinical practice encompasses the full spectrum of liver disease from non-alcoholic steatohepatitis (NASH) to cirrhosis and decompensated liver disease. She is a member of the AASLD/IDSA HCV Guidance committee, advisor to the CDC Coalition for Global Hepatitis Elimination Tip-HepC Registry and advisor to the Hepatitis C Mentor and Support Group.

Continuing Education Credit Information